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Background. Chronic hypoxia has been newly proposed as a
common mechanism of tubulointerstitial fibrosis in the progres-
sion of various chronic inflammatory renal diseases, where plas-
minogen activator inhibitor-1 (PAI-1) plays an important role in
the accumulation of extracellular matrix (ECM) through inhi-
bition of plasmin-dependent ECM degradation. In the present
study, we investigated the presence of PAI-1 in renal tubular
cells by immunostaining renal biopsy samples. We also closely
examined the effects of hypoxia and tumor necrosis factor-a
(TNF-a) on PAI-1 expression in cultured human proximal re-
nal tubular cells (HPTECs).
Methods. Confluent cells growth-arrested in Dulbecco’s mod-
ified Eagle’s medium (DMEM) for 24 hours were exposed to
hypoxia (1% O2) and/or TNF-a at 10 ng/mL for up to 48 hours.
Amounts of PAI-1 protein and mRNA after stimulation were
measured by enzyme-linked immunosorbent assay (ELISA)
and TaqMan quantitative polymerase chain reaction (PCR) or
cDNA array analysis, respectively, and compared to those in
cells incubated under control conditions (18% O2 without TNF-
a). Hypoxia-inducible factor-1a (HIF-1a) was demonstrated by
immunoblot and immunofluorescence analyses. Human PAI-
1 promoter activity was estimated by luciferase reporter gene
assay.
Results. In crescentic glomerulonephritis, clusters of proximal
tubules were specifically stained for PAI-1. cDNA array analy-
sis identified PAI-1 as a major gene highly induced by hypoxia
in HPTECs. Treatment of 24 hours with hypoxia, TNF-a, and
their combination induced a 2.8-fold, a 1.8-fold, and a 4.6-fold
increase in PAI-1 protein secretion, and produced a 3.6-fold, a
3.3-fold, and a 12.1-fold increase at the PAI-1 mRNA level, re-
spectively. Immunoblot analysis and immunocytochemistry re-
vealed that hypoxia-inducible factor-1a (HIF-1a) was markedly
accumulated in the cell lysates and exclusively translocated to
Key words: PAI-1, hypoxia, TNF-a, HIF-1, synergistic effect, human
proximal tubular cells, cDNA array.
Received for publication April 30, 2004
and in revised form October 27, 2004, and February 22, 2005
Accepted for publication March 3, 2005
C© 2005 by the International Society of Nephrology
nuclei after 16 hours’ exposure of HPTECs to hypoxia but
not to TNF-a. Luciferase reporter gene assay showed that hy-
poxia, TNF-a, and their combination increased PAI-1 tran-
scription activity by 1.8-fold, 1.4-fold, and 2.2-fold, respectively.
A dominant-negative form of HIF-1a significantly suppressed
PAI-1 transcription activity induced by hypoxia. Inhibition of
nuclear factor-jB (NF-jB) caused a moderate decrease in PAI-
1 production under hypoxia.
Conclusion. Hypoxia induces PAI-1 expression via remark-
able nuclear accumulation of HIF-1a and partially via NF-jB
activation in HPTECs. TNF-a can synergistically enhance this
hypoxia-induced PAI-1 expression.
Renal fibrosis is characterized by accumulation of
extracellular matrix (ECM), which arises from greater
matrix synthesis than degradation in renal parenchyma
[1–3]. Therefore, inhibition of ECM degradation could
contribute considerably to renal fibrosis. Plasminogen ac-
tivator inhibitor-1 (PAI-1) may play a major role in in-
hibiting the plasmin-mediated ECM degradation system.
PAI-1 is the primary in vivo inhibitor of both tissue-type
and urokinase type plasminogen activators (t-PA and
u-PA) and suppresses the generation of plasmin from
plasminogen [4, 5]. Since plasmin degrades the matrix
proteins, fibronectin, laminin, proteoglycan, and type IV
collagen, and also activates metalloproteinases (MMPs),
which enzymatically cleave collagenous proteins, includ-
ing type I and III collagen [4], plasmin inhibition by PAI-1
probably results in accumulation of intraglomerular and
interstitial ECM. While PAI-1 is essentially undetectable
in normal kidney [6–8], its mRNA and protein are found
near to or within fibrotic lesions in various models of re-
nal fibrosis [7–9] and in many human kidney diseases,
including crescentic glomerulonephritis [10, 11]. PAI-1
knockout mice had attenuated interstitial fibrosis com-
pared with wild-type mice in a renal fibrosis model [12],
and inhibition of the binding activity for vitronectin using
a mutant PAI-1 decreased significantly glomerular matrix
accumulation in experimental glomerulonephritis [13].
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PAI-1 expression is activated in many different types
of cultured cells by growth factors such as tumor necrosis
factor-a (TNF-a) [14] and transforming growth factor-b
(TGF-b) [15], and by metabolic factors such as glucose
[16] and insulin [17]. In renal tubular epithelial cells, TNF-
a, TGF-b , and angiotensin IV were reported to induce
PAI-1 expression [18, 19]. Renal proximal tubule cells un-
der inflammatory conditions may contribute to the evo-
lution of interstitial fibrosis by secreting PAI-1 into the
interstitium as well as ECM proteins [20, 21].
Recently, chronic hypoxia has been proposed as a
common mechanism of tubulointerstitial fibrosis in the
progression of various renal diseases regardless of their
underlying cause [22]. As a major pathogenic factor,
slow but irreversible advancement of preglomerular ar-
teriolosclerosis and glomerulosclerosis has been well
described. This resultant deterioration of the post-
glomerular circulation should cause a substantially
reduced blood flow and reduced oxygen delivery into the
interstitial capillary network, and finally lead to local se-
vere hypoxia in the tubulointerstitium [22]. This notion
is highly probable considering the relatively low oxygen
tension of up to 30 mm Hg (4% O2) even in normal renal
cortex [23, 24]. Experimentally, hypoxia is considered to
be a profibrotic stimulus for tubular epithelial cells similar
to interstitial fibroblasts because these cultured cells in-
crease production of type I and III collagen and decrease
expression of matrix-degrading enzymes under hypoxia
[22, 25]. A key regulator of the cellular response to hy-
poxia is the transcription factor, hypoxia-inducible fac-
tor 1 (HIF-1). HIF-1 is a heterodimer protein composed
of HIF-1a and HIF-1b subunits and activates the tran-
scription of many genes containing a hypoxia response
element (HRE) in the promoter region [22, 26]. HIF-1a
is a pO2-sensitive partner, as it is accumulated under hy-
poxia and unstable under normoxia via a pO2-dependent
degradation involving a ubiqutin-proteasomal pathway
[27]. Although HIF-1 can induce PAI-1 expression in sev-
eral types of cultured cells such as hepatocytes, endothe-
lial cells, and smooth muscle cells through HREs in the
promoter of the PAI-1 gene [28–30], whether or not hy-
poxia induces PAI-1 expression in cultured renal tubular
cells has so far remained to be clarified. Furthermore, it
seems more rational to examine the synergistic effect of
hypoxia and TNF-a, a major proinflammatory cytokine,
on PAI-1 expression in tubular cells, because there are
reports of strong PAI-1 expression in the tubulointersti-
tium, as well as glomeruli in an active form of experimen-
tal glomerulonephritis [31] and in rat cultured proximal
renal tubular cells stimulated by TNF-a [18].
In the current study, we first examined if PAI-1 is actu-
ally present in proximal renal tubular cells in severe forms
of glomerulonephritis. We then investigated the effects of
hypoxia and TNF-a on PAI-1 expression in cultured hu-
man proximal renal tubular epithelial cells (HPTEC) and
further studied their synergistic effects. We also tried to
clarify the signaling pathway activated by hypoxia.
METHODS
Tubular cell cultures
Human proximal tubular epithelial cells (HPTECs)
were purchased as twice-passaged cells from Clonetics,
Inc. (San Diego, CA, USA). The cells were grown in
renal epithelial cell growth medium (REGM) with 5%
CO2 and 18% O2 in a humidified atmosphere at 37.0◦C.
REGM was supplemented with 0.5% fetal bovine serum
(FBS), EGF (10 ng/mL), insulin (5 lg/mL), hydrocorti-
sone (0.5 lg/mL), epinephrine (0.5 lg/mL), triiodothy-
ronine (6.5 ng/mL), transferrin (10 lg/mL), gentamicin
(10 lg/mL), and amphotericin-B (50 ng/mL). The
specific outgrowth of HPTECs was confirmed by the
formation of domes at the microscopic levels [32],
positive staining of gamma-glutamyl transpeptidase on
immunofluorescence analysis [33], and their unique
appearance on electron micrography (Fig. 1). HPTECs
(passage 3 through 5) were seeded in 12-well plates
(3.8 cm2 with 2 mL of medium) at a cell density of 5×104
cells/well or T-175 flasks (175 cm2 with 70 mL of medium).
REGM was renewed every 2 days until confluence was
achieved. Confluent cells were growth-arrested in
Dulbecco’s modified Eagle’s medium (DMEM) (In-
vitrogen Corp., Carlsbad, CA, USA) with 0.5% FBS
(Invitrogen Corp.) for 24 hours, and the DMEM was
renewed immediately before the stimulation experiment.
For hypoxic treatment, the cells were transferred to a
MIC-101 modular incubator chamber (Billups-
Rosenberg, Del Mar, CA, USA) which was flushed
with 1% O2-5% CO2-94% N2, sealed, and placed at
37.0◦C for periods of up to 72 hours. To study the effects
of proinflammatory cytokines on PAI-1 expression,
recombinant human TNF-a (Invitrogen, Gaithersburg,
MD, USA) as a representative inflammatory cytokine
was added to the medium at a final concentration
of 10 ng/mL for various time periods. To study the
effects of nuclear factor-jB (NF-jB) or tyrosine kinase
(TK) inhibition on PAI-1 expression, pyrrolidine-
dithiocarbamate (PDTC, an NF-jB inhibitor) and
genistein (a TK inhibitor) were used, respectively.
Growth-arrested confluent HPTECs were treated with
PDTC (10 lmol/L) or genistein (30 lmol/L) for 2 hours,
and then exposed to hypoxia for 24 to 48 hours. PDTC
was toxic to the cells at concentrations of 15 lmol/L or
more, while genistein had no influence on cell viability
at concentrations between 10 and 50 lmol/L.
Electron microscopy
HPTECs were cultured in REGM on a culture slide
(BD Biosciences, San Jose, CA, USA) for several days
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Fig. 1. Immunohistochemical analyses of PAI-1 protein expression in renal biopsy samples from patients diagnosed as minor glomerular abnor-
malities and crescentic glomerulonephritis. (A) In a renal biopsy sample with minor glomerular abnormalities, no specific staining for PAI-1 was
observed in tubulointerstitium or glomeruli. (B) In crescentic glomerulonephritis, strong PAI-1 staining was focally observed in proximal tubular
cells and in some intraglomerular cells. Original magnification ×100.
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after confluency. When the cells were grown in the dome
formation, they were fixed by immersion in 0.5% glu-
taraldehyde in 0.1 M phosphate-buffered saline (PBS),
pH 7.4, and postfixed in 1% osmium tetroxide for 30
minutes. After a brief wash in PBS they were dehydrated
through ascending grades of alcohol and embbed in epon
resin. Sections were cut on an ultramicrotome. Ultrathin
sections were stained with uranyl acetate and lead citrate
and then examined with an electron microscope (Hitachi
H 600; Hitachi, Tokyo, Japan).
Immunohistochemistry
Immunoperoxidase staining was performed on 4%
paraformaldehyde-fixed paraffin-embedded renal biopsy
samples (2 lm sections) from patients with kidney disease
who gave written informed consent. Rabbit polyclonal
antibody against human PAI-1 (working dilution of 1:100;
Mitsubishi Chemical Corp., Tokyo, Japan) and mono-
clonal mouse antibody against human HIF-1a (working
dilution of 1:40; BD Biosciences) as primary antibody
was used for determining the localization of PAI-1 anti-
gen and HIF-1a, respectively. Positive staining was de-
tected using Envision kit/HRP(DAB) (Dako, Glostrup,
Denmark) according to the manufacturer’s instructions.
For immunodetection of HIF-1a, samples were processed
with trypsin digestion or autoclave treatment.
cDNA array analysis
The cDNA array analysis was performed basically as
reported previously [34] using a commercially available
kit, the GeneNavigator cDNA Array System (Toyobo
Co., Osaka, Japan), according to the manufacturer’s in-
structions. Briefly, HPTECs grown in T-175 flasks were in-
cubated in DMEM with 0.5% FBS under normoxic (18%
O2) or hypoxic (1% O2) conditions for 48 hours. Total
RNA was extracted from the cultured cells using Trizol
Reagent (Invitrogen) according to the manufacturer’s di-
rections. The mRNAs were isolated by incubation with
oligo-dT-magnetic beads (Toyobo Co.) and nonspecific
bindings to beads were washed off. Two kinds of cDNA
array filters, human immunology and human cancer
(Toyobo Co.), were used to detect specific signals of gene
expression. The genes on the human immunology and
cancer filters include 621 immunity-related genes and 550
cancer-related genes, respectively, with 11 housekeeping
genes and 2 non-mammalian genes (pUC and luciferase)
as negative controls. To construct the cDNA probes, re-
verse transcription was performed using a reverse tran-
scriptase, ReverTraAce (Toyobo Co.), poly(dT) linked
with an anchor sequence (Toyobo Co.) as the primer, and
0.2 lg of polyA RNA. cDNA thus synthesized was fur-
ther amplified by PCR using cDNA Amplification Sys-
tem version 2 (Toyobo Co.). The probes were labeled
with biotin by the incorporation of biotin-16-deoxyuracil
triphosphate (dUTP) during the amplification of cDNA.
The filters were preincubated in 20 mL of PerfectHyb hy-
bridization solution (Toyobo Co.) at 68◦C for 30 minutes.
The biotin-labeled probes were denatured and added to
the prehybridization solution. The filters were incubated
in the hybridization mixture at 68◦C overnight. Then they
were washed 3 times with 2× SSC + 0.1% SDS at 68◦C
for 10 minutes, and 3 times with 0.1× SSC + 0.1% SDS
at 68◦C for 10 minutes. Specific signals on the filters were
detected with an Imaging high chemiluminescence detec-
tion kit (Toyobo) according to the manufacturer’s instruc-
tions. CDP-Star (Roche Diagnostics, Tokyo, Japan) was
used as the chemiluminescent substrate. The chemilumi-
nescence image of each filter was gathered with the FAS
1000 system (Toyobo Co.). The gene expression images
were quantified by measuring the intensity of the signals
using an Array-Pro Analyzer (Media Cybernetics, Silver
Spring, MD, USA). Signal intensities of all gene spots
on each filter were converted into relative numbers and
adjusted by setting the median intensity of each whole
filter to a value of 1000. Relative intensities greater than
the averaged values of pUC and luciferase signals were
considered to be suitable for statistical analysis. A change
in gene expression was considered significant only if the
ratio between hypoxic and normoxic samples at 48 hours
was more than 3.0 or less than one third.
Determination of human PAI-1 and TNF-a
antigen concentrations
Concentrations of total PAI-1 in cell culture super-
natants were measured by immunoassay using a com-
mercial analyzer (LPIA 200; Mitsubishi Kagaku Iatron,
Inc., Tokyo, Japan) and a commercially available kit
(LPIA-tPAI Test; Mitsubishi Kagaku Iatron, Inc.) ac-
cording to a method reported recently [35]. This method
had a detection limit of 1.5 ng/mL. The intra- and in-
terassay coefficients of variation were 1.4% and 5.8%,
respectively.
Supernatant TNF-a concentrations were measured by
a commercially available enzyme-linked immunosorbent
assay (ELISA) kit (Quantikine human TNF-a; R&D Sys-
tems, Inc., Minneapolis, MN, USA).
Taqman real-time PCR assay
Total RNA was extracted from cultured cells using Tri-
zol Reagent (Invitrogen) and phenol/chloroform accord-
ing to the manufacturer’s instructions. cDNA synthesis
was performed with a High Capacity cDNA Archive kit
(Applied Biosystems, Foster City, CA, USA) following
the protocol supplied. Reverse transcription was carried
out in a 60-lL volume containing about 2 lg of purified to-
tal RNA, 6 lL of 10× RT buffer, 2.4 lL of 25× NTPs, 6 lL
of 10× random primers, and 150 U of MultiScribe reverse
transcriptase at 25◦C for 10 minutes and then at 37◦C for
Li et al: Hypoxia induces PAI-1 expression in cultured proximal tubular cells 573
2 hours. The TaqMan Real-time RT-PCR was performed
on a TaqMan ABI 7000 sequence Detection System
(Applied Biosystems) using TaqMan Universal PCR
Master Mix (Applied Biosystems). Unlabeled spe-
cific primers and the TaqMan MGB probes (6-FAM
dye-labeled) were purchased from Applied Biosys-
tems for detecting the human PAI-1 gene (Assay
ID: Hs00167155 m1) and TNF-a gene (Assay ID:
Hs00174128 m1). A TaqMan human b-actin MGB (6-
FAM dye-labeled) control reagent kit (Accession No:
NM 001101; Applied Biosystems) was used to detect hu-
man b-actin. After an initial hold of 2 minutes at 50◦C
and 10 minutes at 95◦C, the samples were cycled 40 times
at 95◦C for 15 seconds and 60◦C for 1 minute. PAI-1 and
b-actin cDNA templates were quantified separately us-
ing standard curves of diluted standard cDNA. Here, the
threshold cycle of each sample corresponded with a di-
lution step of the standard cDNA (arbitrary units). For
quantitative analysis, the PAI-1 and TNF-a cDNA con-
tent of each sample was normalized to b-actin as the
housekeeping gene. All TaqMan real-time RT-PCR data
were captured using Sequence Detector Software (SDS
version 1.1; Applied Biosystems).
Immunoblot analysis
Cells were lysed in the lysis buffer (50 mmol/L Tris-
HCl, pH 6.8, 2% SDS). Twenty micrograms of pro-
tein was separated on an 8% SDS-PAGE gel and then
electrophoretically transferred to nitrocellulose mem-
branes (Trans-Blot SD; BioRad, Hercules, CA, USA).
Membranes were blocked overnight with 5% skim milk
powder in Tris-buffered saline, pH 8.0, containing 0.05%
Tween-20 (TBS-T) and then incubated in a 1:100 dilu-
tion (5% skim milk in TBS-T) of primary polyclonal rab-
bit antibody against human PAI-1 (Mitsubishi Kagaku
Iatron, Inc.) or primary monoclonal mouse antibody
against human HIF-1a (BD Biosciences) for 2 hours at
room temperature. Next, the membranes were incubated
for 20 minutes at 37◦C in a 1:1000 dilution (5% skim
milk in TBS-T) of horseradish peroxidase–conjugated
secondary goat antirabbit immunoglobulins (Dako) or
rabbit antimouse immunoglobulins (Dako). Finally, the
secondary antibodies were visualized using enhanced
chemiluminescence (Amersham Life Science, Bucking-
hamshire, England). Purified human PAI-1 (a gift from F.
Furusaki, Mitsubishi Kagaku Iatron Inc.) was used as a
positive control for detecting PAI-1 antigen. In some ex-
periments, signal intensities for specific bands were quan-
tified with a densitometer (Fluorochem; Alpha Innotech
Corp., San Leandro, CA, USA).
Immunofluorescence
HPTECs (passage 3 through 5) were seeded at a cell
density of 2×104 cells/chamber on 4-chamber culture
slides (BD Biosciences) and grown with REGM. Semi-
confluent cells were growth-arrested with DMEM con-
taining 0.5% FBS for 24 hours, and then incubated with
refreshed DMEM for 16 hours under normoxic or hy-
poxic (1%O2) conditions. The cells were fixed in water-
free acetone at room temperature for 10 minutes, and
subjected to plasma membrane and nuclear membrane
permeabilization with 100% methanol at −20◦C for
10 minutes. The cell proteins were blocked with 1%
goat serum in PBS for 60 minutes at room temperature.
Monoclonal mouse antibody against human HIF-1a (BD
Biosciences) was diluted 1:100 in blocking solution and
added to each chamber of the culture slide for 60 minutes
at room temperature. Then, fluorescein isothiocyanate
(FITC)-conjugated rabbit antimouse IgG immunoglobu-
lin (Dako) diluted 1:20 in blocking solution was added for
60 minutes at room temperature in the dark. The stained
cells were photographed under epifluorescence illumina-
tion using an Olympus BH-2 photomicroscope (Olympus,
Tokyo, Japan).
For renal biopsy samples from patients with kidney dis-
ease who gave written informed consent, the renal tissues
were embedded in OCT compound (Miles Laboratories,
Elkhart, IN, USA) and frozen in an acetone-dry ice mix-
ture. The frozen sections were cut at 2 to 3 lm with a cryo-
stat and stored at −80◦C. Cryostat sections were rinsed
in PBS for 15 minutes and fixed in an acetone/methanol
(1:1) mixture on ice. All sections were studied by indirect
immunofluorescence as described above.
Luciferase reporter gene assay
Human proximal tubular epithelial cells (HPTECs)
were seeded in a 24-well plate at a cell density of 5×104
cells/well. The next day, the cells were transfected with
100 ng of pRL-TK control vector and 700 ng of pGL3
PAI-1 wt12345 [36] (a gift from T. Fink, the Danish Can-
cer Society, Aarthus, Denmark) constructed by ligating
the human PAI-1 promoter spanning −806 to +19 to the
luciferase reporter plasmid, pGL3basic [36] using
lipofect-amine 2000 (Invitrogen Corp.) and OPTI-MEN
(Invitrogen Corp.). Several hours later, the transfection
medium was replaced with DMEM with TNF-a (10 ng/
mL) or without TNF-a. For hypoxic treatment, the trans-
fected cells were transferred to a MIC-101 modular incu-
bator chamber (Billups-Rosenberg), which was flushed
with 1% O2 −5% CO2 −94% N2, sealed and placed at
37.0◦C for 18 hours. For normoxic treatment, the cells
were placed in a humidified atmosphere of 5% CO2 and
95% air at 37◦C for 18 hours. Finally, the cells were lysed
in the lysis buffer, and firefly luciferase and renilla lu-
ciferase activities in the lysates were determined with a
luminometer using the dual-luciferase reporter assay kit
(Promega Corp., Madison, WI, USA).
In order to study interrelationship between HIF-
1a and PAI-1 expression, cotransfection assays were
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performed with expression vectors coding a constitutively
activated (CA) form of human HIF-1a (pCMV-FLAG-
HIF-1a−CA) and a dominant negative (DN) form of hu-
man HIF-1a (pCMV-FLAG-HIF-1a-DN) [37]. HPTECs
were cotransfected with 350 ng of pCMV-FLAG-HIF-
1a−CA, pCMV-FLAG-HIF-1a-DN, or pCMV and 100
ng of pRL-TK control vector and 550 ng of pGL3 PAI-1
wt12345.
Statistic analyses
All samples were run in triplicate, and the results were
presented as the mean and standard deviation (±SD).
Experiments were performed at least 2 times, and results
from typical experiments are shown in the figures. The
unpaired t test was used to evaluate the significance of
differences between 2 groups of experiments. The anal-
ysis of covariance with Scheffe’s post hoc test was used
for multiple comparisons. A two-tailed P value less than
0.05 was considered statistically significant.
RESULTS
Immunohistolocalization of PAI-1 and HIF-1a antigen
in normal and diseased kidneys
No specific staining for PAI-1 was found in renal biopsy
samples from patients with minor glomerular abnormal-
ities (Fig. 1A), minimal change nephrotic syndrome, or
membranous nephropathy (data not shown). In contrast,
in renal biopsy samples of patients diagnosed as crescen-
tic glomerulonephritis (N = 3), intense staining for PAI-1
was observed, particularly in the cytoplasm in clusters of
proximal renal tubular cells (Fig. 1B). Weak staining for
PAI-1 was diffusely found within the ECM expansion in
some areas of interstitial fibrosis, while fibrotic changes
were rarely observed just adjacent to the proximal tubular
cells positive for PAI-1. In the glomeruli, a small number
of mesangial cells, and probably infiltrating macrophages
were positive for PAI-1.
As for HIF-1a, we were not able to detect specifically
the antigen in the frozen sections or paraformaldehyde-
fixed samples processed with or without trypsin or auto-
clave treatment (data not shown).
Morphologic characteristics of HPTECs
and PAI-1 production
Electron microscopy revealed that HPTECs had mi-
crovilli on the apical membranes and tight junctions on
the basolateral membranes, with a clear intracellular po-
larization that is characteristic of proximal renal tubular
epithelial cells (Fig. 2). Immunoblot analysis using poly-
clonal antibody for human PAI-1 showed that PAI-1 anti-
gen was actually present as a single band of about 50 kD in
whole cell lysates from HPTECs incubated with DMEM
for 24 hours after reaching confluency (Fig. 3).
Fig. 2. Electron micrograph of cultured human proximal tubular ep-
ithelial cells. The cells displayed microvilli on the apical membranes (∗)
and tight junctions on the basolateral membranes (arrow) with clear
intracellular polarization. Original magnification ×3000.
77 kD
50 kD
34.3 kD
Positive
control
18%O2
Fig. 3. Immunoblot analysis of PAI-1 in whole cell lysates of human
proximal tubular epithelial cells incubated with DMEM for 24 hours
after reaching confluency. Human PAI-1 protein was identified as a
single 50-kD band using polyclonal anti-human PAI-1 antibody.
Effect of hypoxia on viability of HPTECs and screening
of hypoxia-induced genes by cDNA array analysis
To investigate the effects of hypoxia on the viability
of HPTECs in vitro, cells incubated under normoxic and
hypoxic conditions were observed by microscopy every
day up to day 3. There were no detectable variations in
cell morphology at the microscopic level between the cells
under hypoxia (1% O2) and normoxia (18% O2). There
were no necrotic or apoptotic cellular changes assessed by
LDH release into the medium during hypoxic treatment
(data not shown).
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Before investigating more closely the hypoxic effects
on PAI-1 expression, we screened and ranked hypoxia-
induced genes in HPTECs by expression microarray anal-
ysis using 2 kinds of cDNA array filters containing the
PAI-1 gene. The analysis using the human immunology
filter (621 genes) revealed that only 5 genes were signifi-
cantly up-regulated after 48 hours of hypoxia. The anal-
ysis using the human cancer filter (550 genes) showed
that only 16 genes were significantly up-regulated by hy-
poxia. The data for genes ranked first to fifth in the up-
regulation ratio among all the genes tested are shown in
Table 1. The marked induction of glucose transporter-1
(Glut-1), a representative of hypoxia-induced genes, ver-
ified that hypoxic conditions were achieved in the culture
(Table 1). In both analyses, PAI-1 proved to be one of
the major genes highly induced by hypoxia: a 6.1-fold in-
crease for the human immunology filter and a 4.0-fold
increase for the human cancer filter (Table 1). Therefore,
these findings encouraged us to perform further detailed
experiments that are described below.
Effect of hypoxia on PAI-1 production in HPTECs
Amounts of PAI-1 mRNA in the cells under hypoxic
conditions were significantly increased by 2.0-fold at
6 hours, by 6.6-fold at 24 hours, and by 5.4-fold at
48 hours compared with those in the normoxic control
cells at 6 hours (Fig. 4A). The supernatant PAI-1 concen-
trations in cells maintained under hypoxia were signifi-
cantly increased by 1.2-fold at 6 hours, by 3.7-fold at 24
hours, and by 8.4-fold at 48 hours compared with those
for the normoxic control cells at 6 hours (Fig. 4B). As for
mRNA levels, the effect of hypoxia reached a maximal
level at 24 hours and remained almost stable for up to
48 hours.
Effect of TNF-a on PAI-1 production in HPTECs
Figure 5 shows that the stimulation with TNF-a
(10 ng/mL) increased the PAI-1 expression by HPTECs.
PAI-1 mRNA level in the cells treated with TNF-a were
significantly increased by 3.3-fold at 24 hours, and by 2.2-
fold at 48 hours compared with those in the control cells
at 24 hours (Fig. 5A). The supernatant PAI-1 concen-
trations in the cells treated with TNF-a under normoxic
conditions were significantly increased by 1.8-fold at
24 hours, and by 3.1-fold at 48 hours compared with those
for the control cells without TNF-a treatment at 24 hours
(Fig. 5B). Induction of PAI-1 expression by TNF-a was
observed for up to 48 hours, reaching a maximal level
of PAI-1 mRNA at 24 hours, and PAI-1 concentrations
in the supernatants steadily increased with and without
TNF-a treatment.
Synergistic effect of hypoxia and TNF-a on PAI-1
production in HPTECs
In order to clarify the synergistic effect on the PAI-
1 expression, the cells were treated simultaneously with
a combination of hypoxia and TNF-a. Stimulation with
both hypoxia and TNF-a together for 24 hours resulted
in strong synergistic induction of PAI-1 expression by
HPTECs (Fig. 6A and B). PAI-1 mRNA and protein lev-
els after the combined stimulation were increased sig-
nificantly compared with those after a single stimulation
of hypoxia or TNF-a alone (Fig. 6A and B). Hypoxia
together with TNF-a increased synergistically the PAI-
1 mRNA amount by 12.0-fold (Fig. 6A) and the PAI-1
secretion rate by 4.6-fold (Fig. 6B) compared with the
values for unstimulated control cells, while hypoxia or
TNF-a alone increased the mRNA amount by 3.6-fold
or by 3.3-fold, and the protein secretion rate by 2.7-fold
or by 1.8-fold, respectively (Fig. 6B).
Intracellular accumulation and nuclear translocation of
HIF-1a in HPTECs under hypoxic conditions
Immunoblot analysis demonstrated that HIF-1a pro-
tein was markedly accumulated in the whole cell lysates
after hypoxic treatment of 16 hours compared with that
for the cells cultured under conditions of normoxia
(Fig. 7A). There was no difference in the relative amounts
of HIF-1a protein between cells with and without TNF-a
treatment under either normoxic (N = 4, 1.041 ± 0.177
vs. 1.0 ± 0.113, NS) or hypoxic conditions (N = 4, 0.922 ±
0.164 vs. 1.0 ± 0.049, NS) (Fig. 7B). Immunofluorescence
analysis demonstrated that HIF-1a was accumulated and
translocated exclusively to nuclei of HPTECs after 16-
hour exposure of the cells to hypoxia (Fig. 8), which was
consistent with the results of the immunoblot analysis
(Fig. 7A).
Activation of PAI-1 promoter by hypoxia, TNF-a,
and their combination
To investigate whether or not hypoxia, TNF-a, and
their combination actually increase the transcriptional ac-
tivity of the human PAI-1 promoter, transient transcrip-
tion assay using pGL3 PAI-1 was carried out in HPTECs
treated under normoxic and hypoxic conditions for
18 hours. Hypoxia or TNF-a alone increased the tran-
scriptional activity by 1.8-fold and by 1.4-fold, respec-
tively, compared with the control (Fig. 9). Simultaneous
stimulation by hypoxia and TNF-a produced a further in-
crease in the activity by up to 2.3-fold (Fig. 9), supporting
the synergistic effect of the 2 factors on PAI-1 expression
as described above (Fig. 6).
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Table 1. List of major genes highly up-regulated by hypoxia in human proximal renal tubular epithelial cellsa
GenBank Expression ratio
cDNA array filter used Gene names (Accession no.) (1%O2/18%O2)b
PAI-1 M16006 6.1
Glut 1 K03195 5.7
Human immunology filterc CD6 X60992 4.6
CD8 alpha M12828 4.1
Ephrin-A1 M57730 3.9
MUC-1 X80761 6.8
PCTAIRE-3 X66362 4.4
Human cancer filterc PAI-1 M16006 4.0
DDR-1 Z29093 3.9
IGF-BP3 M35878 3.9
Changes in gene expression between normoxia and hypoxia were determined using cDNA array analysis. Expression ratio indicates the ratio of gene expression
during hypoxia (1%O2) to that during normoxia (18%O2). Data of genes ranking first to fifth in the expression ratio among all the genes tested are listed for each filter.
List of the genes on each filter is shown at http://www.toyobo.co.jp./seihin/xr/lifescience. html.
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Fig. 4. PAI-1 production by human proximal tubular epithelial cells (HPTECs) during normoxic (,18% O2) and hypoxic (, 1% O2) treatment
for up to 48 hours. (A) cDNA was prepared from total cellular RNA extracted from treated HPTECs at the indicated time points, and TaqMan
real-time PCR for PAI-1 and b-actin was performed. PAI-1 mRNA amounts were normalized to b-actin. Averaged amounts of PAI-1 mRNA for
cells during normoxia at 6 hours were set to 1.0. (B) Supernatants were also harvested at the indicated time points, and assessed for PAI-1 protein
by immunoassay. Results were expressed as the mean ± SD of experiments done in triplicate (N = 6). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001
compared with the control cells at each time point, by unpaired t test.
Inhibition of hypoxia-induced PAI-1 promoter activation
by a dominant-negative form of HIF-1a
To investigate interrelationship between HIF-1a and
PAI-1 expression, HPTECs were cotransfected with ex-
pression vectors encoding a constitutively activated (CA)
form of human HIF-1a, a dominant-negative (DN) form
of HIF-1a, or no protein (empty vector), in conjunction
with pGL3 PAI-1. Expression of a DN form of HIF-1a
abolished PAI-1 promoter activity induced by hypoxia
(Fig. 10). Under hypoxic conditions, expression of a con-
stitutively activated form of human HIF-1a produced
a further increase in the promoter activity compared
with empty vector cotransfection (Fig. 10). Under nor-
moxic conditions, PAI-1 promoter activity was slightly but
not significantly increased at 24 hours after transfection
(Fig. 10), and significantly increased by 1.4-fold at
30 hours in cells transfected with the CA-form HIF-1a
expression vector relative to those transfected with the
empty vector (fold increase: 1.40 ± 0.11 vs. 1.00 ± 0.06, P
< 0.01).
Effects of NF-jB and TK inhibitors on hypoxia-induced
PAI-1 expression
Treatment with an NF-jB inhibitor, PDTC (10 lmol/
L), caused a 35% decrease in the hypoxia-induced PAI-1
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Fig. 5. PAI-1 production by human proximal tubular epithelial cells (HPTECs) during normoxic treatment in the absence () or presence () of
TNF-a (10 ng/mL) for 24 and 48 hours. (A) After 24 hours and 48 hours of treatment with and without TNF-a, cDNA was prepared from total
cellular RNA extracted from HPTECs, and TaqMan real-time PCR for PAI-1 and b-actin was performed. PAI-1 mRNA amounts were normalized
to b-actin. Averaged amounts of PAI-1 mRNA for cells untreated with TNF-a at 24 hours were set to 1.0. (B) Supernatants were also harvested
after 24-hour and 48-hour treatments, and assessed for PAI-1 protein by immunoassay. Results were expressed as the mean ± SD of experiments
done in triplicate (N = 6). ∗P < 0.05 and ∗∗P < 0.001 compared with the control cells at each time point, by unpaired t test.
production at the mRNA level at 24 hours, and a 27%
decrease at the supernatant protein level at 48 hours,
while it did not change PAI-1 production under normoxia
(Fig. 11). In the cells under hypoxia, treatment with a TK
inhibitor, genistein (30 lM), significantly decreased the
supernatant PAI-1 concentrations at 48 hours (37.3 ± 1.8
vs. 46.2 ± 5.9 ng/mL, P < 0.01), and produced a 38% de-
crease in the hypoxic PAI-1 induction, while there was no
difference in PAI-1 production at 48 hours between cells
with and without the treatment under normoxia (22.7 ±
0.7 vs. 23.1 ± 1.6 ng/mL, NS). Treatments with genistein at
concentrations between 30 and 50 lmol/L did not differ in
the reduction rate of hypoxia-induced PAI-1 production
(data not shown).
Effects of hypoxia on TNF-a expression in HPTECs
No significant difference was observed in the mRNA
(1.59 ± 1.03 vs. 1.0 ± 0.52, NS) or supernatant protein
levels (8.3 ± 0.9 vs. 8.3 ± 1.3 pg/mL, NS) of TNF-a at
24 hours between the cells under hypoxia and those under
normoxia.
DISCUSSION
Here, we reported for the first time that hypoxia in-
duced PAI-1 expression at the mRNA and protein levels
in cultured human proximal renal tubular epithelial cells,
and that PAI-1 was identified as one of the major genes
up-regulated by hypoxia along with Glut-1 [23]. Although
it cannot be denied that the degradation rate of mRNA
was reduced under hypoxia in the cultured tubular cells, it
seems likely that increased transcriptional activity rather
than reduced degradation of PAI-1 mRNA occurs under
hypoxia, because a recent study showed that the half-time
of PAI-1 mRNA was not affected by hypoxia [29].
PAI-1 is generally accepted to be involved in reduced
degradation and resultant accumulation of ECM, leading
to renal fibrosis [4, 5, 38]. Therefore, the hypoxia-induced
PAI-1 production could account in part for the putative
profibrotic effects of hypoxia [22]. Evidence has been ac-
cumulating that chronic hypoxia could serve as a common
mechanism of tubulointerstitial fibrosis in the progres-
sion of various renal diseases [22, 39–41]. Hypoxia was
reported to increase production of type I and III colla-
gens (interstitial type collagens), and to decrease expres-
sion of matrix-degrading enzymes (MMP-1, -2, and -9)
in tubular epithelial cells or interstitial fibroblasts [22,
25, 39]. Cultured proximal tubular cells secrete PAI-1
to the apical and basolateral sides to almost an equal
degree [18]. PAI-1 secreted to the basolateral side by
proximal tubular cells may aggregate within the tubu-
lointerstitial space due to high affinity for vitronectin, a
ubiquitous component of ECM [4, 13], and may inhibit
plasmin- and MMP-mediated ECM degradation, possibly
leading to ECM accumulation and ensuing renal fibrosis.
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B Fig. 7. Immunoblot analyses of HIF-1a inhuman proximal tubular epithelial cells
(HPTECs) treated with or without hypoxia
(1% O2) in the presence or absence of TNF-a
(10 ng/mL). (A) Whole cell lysates were pre-
pared from HPTECs cultured with DMEM
under normoxic or hypoxic conditions for 16
hours. Lysates of HEK293 cells treated under
conditions of hypoxia (1% O2) for 4 hours
were used as a positive control. (B) Whole cell
lysates were prepared from HPTECs cultured
with DMEM under normoxic or hypoxic con-
ditions in the presence or absence of TNF-a
(10 ng/mL).
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Fig. 8. Immunofluorescence of HIF-1a in human proximal tubular epithelial cells (HPTECs) treated under normoxic (A) (18% O2) or hypoxic
(B) (1% O2) conditions for 16 hours. (A) Faint HIF-1a staining was observed in the cytoplasm or nucleus of HPTECs. (B) Strong HIF-1a staining
was observed predominantly in the nuclei of HPTECs. Original magnification ×400.
However, in our preliminary experiment using a cDNA
array, bidirectional events of ECM degradation were ob-
served. Namely, in addition to PAI-1, tissue inhibitor of
matrix-metalloproteinase (TIMP)-1, a common inhibitor
of MMPs, was abundantly expressed under basal con-
ditions and further up-regulated by hypoxia (2.3-fold),
while main degrading enzymes for interstitial collagens,
MMPs-1 and 3, were also increased at mRNA levels after
hypoxic treatment of HPTECs (1.3- to 1.5-fold). Strictly,
to clarify whether or not hypoxia actually reduces total in
vivo ECM-degrading activity, in situ zymography, as per-
formed in a recent detailed study [42], will be required
for hypoxic kidney tissue.
Another important role of hypoxia-induced PAI-1 pro-
duction by HPTECs may be the promotion of neovas-
cularization in the peritubular area after hypoxic injury.
Many recent studies showed that inhibition of proteolysis
by PAI-1 in cooperation with growth stimulation by vas-
cular endothelial growth factor (VEGF) is necessary for
microvessel outgrowth [43–46]. Recently, expression of
VEGF was reported in the damaged tubules of kidneys
[47] and cultured human proximal tubular cells treated
under hypoxic conditions [48]. In our preliminary exper-
iment using the real-time PCR assay, we observed that
hypoxia induced expression of PAI-1 and VEGF mRNA
in HPTECs (data for VEGF not shown). Therefore, prox-
imal tubular cells may produce circumstances suitable
for neovascularization when they are exposured to hy-
poxic conditions. However, PAI-1 appears to play a much
greater role as a profibrotic factor than as an angiogenetic
factor, considering that it is essentially the main inhibitor
for the fibrin- and ECM-degrading systems but is merely
an assistant for neovascularization, which requires many
other indispensable stimulators.
We also found that in the HPTECs, hypoxia induced
the nuclear accumulation of HIF-1a and subsequently
increased the transcriptional activity of the promoter for
the human PAI-1 gene through the accumulated HIF-
1a. These findings are supported by the observation
that HIF-1 interaction with the hypoxia-response ele-
ment (HRE) 2 site of the human PAI-1 promoter pro-
voked PAI-1 gene transcription in human hepatocytes
under hypoxic conditions [36]. As for actual presence
of HIF-1a protein in renal biopsy samples, we were not
able to identify the protein in renal tissues from patients
with crescentic glomerulonephritis. Our failure may have
resulted in part from the delayed fixation of the renal
biopsy samples. In rat kidneys perfusion-fixed in situ im-
mediately after hypoxic treatment, in vivo activation of
HIF isoforms was observed clearly and specifically [49,
50]. Marked nuclear accumulation of HIF-1a protein
was identified in the proximal tubular cells of mature
rat kidney after hypoxic stimulus, and intensive stain-
ing for HIF-1a was colocalized with the expression of
the target gene, heme oxygenase-1 [49]. Another iso-
form of HIF-1, HIF-2a, was also stained in the nuclei
of proximal convoluted tubular cells of newborn mouse
kidney [50].
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Considering the relatively low oxygen tension of up to
30 mm Hg (4% O2) in even normal renal cortex [23, 24],
it seems probable that renal parenchyma are inevitably
exposed to hypoxia enough to accumulate and activate
HIF-1a as chronic renal disease advances, although we
could not obtain evidence showing the actual in vivo exis-
tence of HIF-1a. In our preliminary study using HPTECs,
moderate hypoxia (4% O2) produced a scant 1.2-fold in-
crease in supernatant PAI-1 concentrations at 24 hours,
compared with that under normoxia. As shown in the
Results section, severe hypoxia (1% O2) caused a more
than 2-fold increase in PAI-1 concentrations at 24 hours.
Therefore, it is highly likely that severe hypoxia in vivo
produces a further increase in PAI-1 production, com-
pared to that under moderate hypoxia, and plays a patho-
logic role in the progression of kidney disease.
The use of an NF-jB activation inhibitor (PDTC) and
a TK inhibitor (genistein) provided information on the
signal pathways activated by hypoxia in HPTECs. PDTC
serves as an inhibitor of NF-jB activation via suppression
of IjB release from its NFkB complex [51]. Genistein in-
hibits the c-src (TK)-dependent phosphorylation of IjB
and thereby blocks NFkB activation [52–54], while hy-
poxia induces c-src activation [55]. In our study, PDTC
and genistein partially blocked the hypoxia-induced PAI-
1 production, which was consistent with results already
reported for cultured endothelial cells [29]. Therefore,
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Fig. 10. HIF-1a dependency of PAI-1 promoter activation in human
proximal tubular epithelial cells (HPTECs) during normoxic (,18%
O2) and hypoxic (, 1% O2) treatment. HPTECs were cotransfected
with expression vectors encoding a constitutively activated form of hu-
man HIF-1a (CA), a dominant-negative form of human HIF-1a (DN),
or no protein (EV) together with pGL3 PAI-1. After 6 hours, the trans-
fection medium was replaced with DMEM and cells were incubated
under normoxic or hypoxic conditions for 18 hours, and then harvested
for luciferase assays. Luciferase activity of cells treated was determined
relative to that of cells transfected with the empty vector and incubated
under normoxic conditions for 18 hours. Results were expressed as the
mean ± SD of experiments done in triplicate (N = 6). ∗P < 0.05, ∗∗P
< 0.01 and NS (not significant) compared with cells incubated under
the indicated conditions, by one-way analysis of variance with Scheffe’s
post hoc comparison.
our new findings together with recent data suggest the
possible involvement of NFjB activation in the mech-
anism by which hypoxia produces PAI-1 induction in
HPTECs.
In inflammatory glomerulonephritis with crescent
formation or necrotizing lesions [7, 9, 10, 56], PAI-1 ex-
pression was up-regulated especially in glomeruli, colo-
calizing with fibrin, while it was undetectable in normal
mouse and human kidneys [6–8]. However, in the cur-
rent study, strong staining for PAI-1 was identified in
proximal tubular tissues with much less labeling in in-
traglomerular cells in renal biopsy tissues of crescen-
tic glomerulonephritis (Fig. 1B). On the other hand,
no staining for PAI-1 was observed in any tubules or
glomeruli of renal biopsy samples from heavy protein-
uric patients with membranous nephropathy and minimal
change nephrotic syndrome (data not shown). Therefore,
the deposition of PAI-1 antigen in the proximal renal
tubules might have resulted from protein synthesis by the
tubules rather than the cellular absorption of glomerular
filtrates. In a previous report [18], TNF-a increased the
expression of PAI-1 mRNA and protein in rat cultured
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(, 18% O2) and hypoxic (, 1% O2) treatment. Confluent HPTECs were treated with or without PDTC (10 lmol/L) for 2 hours and then
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and ∗∗∗P < 0.001, compared with the control cells at each time point, by unpaired t test.
proximal tubular cells. Then, we attempted to examine
the effect of TNF-a on PAI-1 production in HPTECs and
found that TNF-a increased PAI-1 expression at both the
mRNA and protein levels, supporting the previous re-
sults of rat tubular cells [18]. This result may be rational-
ized by the consistent finding that the human PAI-1 pro-
moter contains known consensus cis regulatory elements
to bind transcription factors such as activated protein-1
(AP-1) and NF-jB [5], which are specific mediators for
the execution of TNF-a effects. Additionally, an in vivo
association of PAI-1 with TNF-a in the kidney may be
supported by our preliminary finding that urinary PAI-1
levels were positively correlated to urinary TNF-a levels
in patients with crescentic glomerulonephritis (data not
shown).
PAI-1 staining was also observed within the ECM ex-
pansion, forming interstitial fibrosis in a small number
(N = 3) of renal biopsy samples showing crescentic
glomerulonephritis. This implies that secreted PAI-1 from
cells may be associated with ECM and may retard its
degradation. However, just adjacent to the proximal
tubular cells positive for PAI-1, fibrotic changes were
hardly found. The intracellular PAI-1 deposition in tubu-
lar cells may be a surrogate for ensuing fibrotic changes in
the neighboring area, rather than advanced fibrosis, be-
cause PAI-1 is generally produced in tubular cells being
activated by inflammatory cytokines or hypoxia, but not
in the severely atrophied cells.
Concerning the mechanism for the synergistic effect
of hypoxia and TNF-a on PAI-1 expression in HPTECs,
we were not able to detect TNF-a–induced HIF-1a accu-
mulation in the whole cell lysates from HPTECs during
either normoxia or hypoxia (Fig. 7), although IL-1b was
reported to increase the amount of HIF-1a in the whole
cell extracts from HPTECs incubated under conditions
of normoxia [48]. Our finding that hypoxia did not in-
crease TNF-a production eliminated the possibility that
hypoxia-induced TNF-a may have a synergistic effect on
PAI-1 production. However, hypoxia-induced NF-jB ac-
tivation may account in part for the synergistic effect, in
cooperation with TNF-a. Furthermore, other hypoxia-
induced growth factors not identified in this study may
cause the synergistic effect. It also remains to be clari-
fied whether or not TNF-a enhances the DNA binding
activity of HIF-1 in HPTECs, because TNF-a and IL1-b
induced HIF-1 activity by increasing DNA binding capa-
bility in a human hepatoma cell line [57].
CONCLUSION
Hypoxia increased the expression of PAI-1 mRNA and
protein via the intracellular accumulation of HIF-1a and
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its exclusive nuclear translocation, and partially via NFjB
activation in cultured human proximal tubular epithelial
cells. TNF-a also induced PAI-1 expression in cultured
proximal tubular cells. Furthermore, hypoxia and TNF-a
synergistically enhanced their PAI-1-inducing effect in
the cultured cells, which appears to promote the progres-
sion of chronic inflammatory renal disease.
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